Intestinal obstruction in pregnancy by ondansetron

Rana Cohen, Meital Shlomo, Dorit Nahlieli Dil, Natalia Dinavitser, Mati Berkovitch, Gideon Koren

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Background: Ondansetron use for nausea and vomiting during pregnancy has increased in the last years, although its maternal and fetal safety is not conclusive. Case: We describe a case of intestinal obstruction in a pregnant woman with severe nausea and vomiting of pregnancy treated with ondansetron, which is known to slow gut motility. Conclusion: The spontaneous reporting system of WHO confirms that this potentially life threatening complication is more common than what the peer review literature may suggest and needs to be looked into carefully, especially in view of the wide spread off-label use for NVP.

Original languageEnglish
Pages (from-to)152-153
Number of pages2
JournalReproductive Toxicology
StatePublished - 1 Dec 2014
Externally publishedYes


  • 5-HT3 receptor antagonist
  • Adverse event
  • Hyperemesis gravidarum
  • Intestinal obstruction
  • Ondansetron
  • Pregnancy


Dive into the research topics of 'Intestinal obstruction in pregnancy by ondansetron'. Together they form a unique fingerprint.

Cite this